Table 3.

Rates of clinician agreement with patient-reported symptomatic toxicities, by grade level of patient reports, when patient-reported toxicities were shared with clinicians in a phase 2 clinical trial (N = 44).

Patient-reported grade level	Total # reported by patients	Clinician agreed # (%)	Clinician upgraded # (%)	Clinician downgraded # (%)
Grade 0	6158	6000 (97%)	152 (2%)	Not applicable
Grade 1	2553	2407 (94%)	94 (3.5%)	49 (2%)
Grade 2	731	471 (64%)	4 (<1%)	253 (35%)
Grade 3	168	47 (28%)	Not applicable	121 (72%)